Notch Signalling in the Hippocampus of Patients With Motor Neuron Disease

被引:20
|
作者
Gomez-Pinedo, Ulises [1 ]
Galan, Lucia [2 ]
Matias-Guiu, Jordi A. [2 ]
Pytel, Vanesa [1 ,2 ]
Moreno, Teresa [2 ]
Guerrero-Sola, Antonio [2 ]
Matias-Guiu, Jorge [1 ,2 ]
机构
[1] Univ Complutense Madrid, Lab Neurobiol, IdISSC, Hosp Clin San Carlos,Inst Neurosci, Madrid, Spain
[2] Univ Complutense Madrid, Dept Neurol, IdISSC, Hosp Clin San Carlos,Inst Neurosci, Madrid, Spain
来源
FRONTIERS IN NEUROSCIENCE | 2019年 / 13卷
关键词
ALS; Notch; NICD; APP; ADAM10; ADAM17; BACE1; hippocampal neurogenesis; AMYOTROPHIC-LATERAL-SCLEROSIS; INTRACELLULAR DOMAIN; TSPANC8; TETRASPANINS; ADULT; APP; PROTEIN; ACTIVATION; PATHWAY; ALZHEIMERS; CLEAVAGE;
D O I
10.3389/fnins.2019.00302
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: The Notch signalling pathway regulates neuronal survival. It has some similarities with the APP signalling pathway, and competes with the latter for alpha- and gamma-secretase proteolytic complexes. The objective of this study was to study the Notch signalling pathway in the hippocampi of patients with motor neuron disease. Methods: We studied biological material from the autopsies of 12 patients with motor neuron disease and 4 controls. We analysed the molecular markers of the Notch and APP signalling pathways, TDP43, tau, and markers of neurogenesis. Results and Conclusion: Low NICD expression suggests Notch signalling pathway inactivation in neurons. Inactivation of the pathway despite increased Notch1 expression is associated with a lack of alpha-secretase expression. We observed increased beta-secretase expression associated with activation of the amyloid cascade of APP, leading to increases in amyloid-beta and AICD peptides and decreased levels of Fe65. Inactivation of the Notch signalling pathway is an important factor in decreased neurogenic response in the hippocampi of patients with amyotrophic lateral sclerosis.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] PTEN signalling in motor neuron disease (ALS & SMA)
    Ning, K.
    Drepper, C.
    Valori, C. F.
    Wyles, M.
    Ismail, A.
    Higginbottom, A.
    Herrmann, T.
    Shaw, P. J.
    Sendtner, M.
    Azzouz, M.
    HUMAN GENE THERAPY, 2011, 22 (10) : A64 - A64
  • [2] INVOLVEMENT OF THE AMYGDALA, DENTATE AND HIPPOCAMPUS IN MOTOR-NEURON DISEASE
    ANDERSON, VER
    CAIRNS, NJ
    LEIGH, PN
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 129 : 75 - 78
  • [3] CLUSTERS OF PATIENTS WITH MOTOR-NEURON DISEASE
    PAMPHLETT, R
    MEDICAL JOURNAL OF AUSTRALIA, 1990, 153 (11-12) : 742 - 743
  • [4] Decremental responses in patients with motor neuron disease
    Alanazy, Mohammed H.
    Hegedus, Janka
    White, Chris
    Korngut, Lawrence
    BRAIN AND BEHAVIOR, 2017, 7 (11):
  • [5] Motor neuron disease in patients with HIV infection
    Lorenzoni, Paulo
    Ducci, Renata
    Dalladone, Giuliano
    Kay, Claudia
    Werneck, Lineu
    Scola, Rosana
    NEUROLOGY, 2017, 88
  • [6] FUS pathology in patients with motor neuron disease
    Fujita, Y.
    Fujita, S.
    Takatama, M.
    Aizawa, H.
    Mihara, B.
    Watanabe, M.
    Ikeda, M.
    Okamoto, K.
    BRAIN PATHOLOGY, 2010, 20 : 31 - 31
  • [7] NEUROTRANSMITTER ABNORMALITIES IN PATIENTS WITH MOTOR NEURON DISEASE
    BELENDIUK, K
    BELENDIUK, GW
    FREEDMAN, DX
    ANTEL, JP
    ARCHIVES OF NEUROLOGY, 1981, 38 (07) : 415 - 417
  • [8] COMMUNICATION AIDS IN PATIENTS WITH MOTOR NEURON DISEASE
    PERRY, AR
    GAWEL, M
    ROSE, FC
    BRITISH MEDICAL JOURNAL, 1981, 282 (6277): : 1690 - 1692
  • [9] SUICIDE IN PATIENTS WITH MOTOR-NEURON DISEASE
    BAK, S
    STENAGER, EN
    STENAGER, E
    BOLDSEN, J
    SMITH, TA
    BEHAVIOURAL NEUROLOGY, 1994, 7 (3-4) : 181 - 184
  • [10] Extra motor neuron lesion in neuropsychologically abnormal Motor Neuron Disease patients but without dementia
    Al-Sarraj, S
    Blatman, J
    Doey, L
    Kibble, M
    Maekawa, S
    Glodstein, L
    Leigh, N
    JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (06) : VIII - VIII